首頁‎ > ‎未命名‎ > ‎

2018.10

張貼者:2018年11月2日 上午1:26Service Center   [ 已更新 2018年11月2日 上午2:10 ]

碁米庫斯生技所開發的產品「抗生素的測試及篩選平台」已被法國知名製藥公司Antabio用來研發新抗生素,Antabio對此產品的評註如下: Developing new treatments effective against Gram-negative pathogens is one of the major challenges for public healthcare systems.  The discovery of new antimicrobial therapies targeting these bacteria is extremely difficult because of their intrinsic resistance of these bacteria due to low permeability of the Gram-negative cell envelope combined with efficient drug efflux mechanisms.  Therefore the development of tools such as the Kemyth Biotech library of genetically engineered K. pneumoniae mutants is important to facilitate research to these mechanisms.  The discovery team at Antabio uses the tools developed by Kemyth Biotech as an essential part of its research and development process.”  Nicolas Sprynski, Head of Discovery Biology, Antabio 


Comments